This case report and literature review highlighted the importance of confirming the genetic profile of EGFR mutated lung adenocarcinoma showing SQ transformation as resistance to EGFR TKI, and treatment with individualized EGFR TKI doses. The gene discussed is EGFR; the disease is lung adenocarcinoma.